Jefferies Group LLC Amylyx Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Sep 21, 2023
SELL
$17.15 - $30.92 $391,019 - $704,976
-22,800 Reduced 45.6%
27,200 $758,000
Q3 2022

Nov 14, 2022
SELL
$17.15 - $30.92 $391,019 - $704,976
-22,800 Reduced 45.6%
27,200 $766,000
Q2 2022

Sep 21, 2023
BUY
$6.85 - $19.93 $156,180 - $454,404
22,800 Added 83.82%
50,000 $963,000
Q2 2022

Aug 15, 2022
BUY
$6.85 - $19.93 $342,500 - $996,500
50,000 New
50,000 $963,000

Others Institutions Holding AMLX

# of Institutions
142
Shares Held
49.1M
Call Options Held
281K
Put Options Held
438K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $211M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email